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ID copper(II) complex,  [Cu2(L)2(fum)]∙H2O}n (1) has been synthesized using  fumarate (fum
2-) 
and a Schiff base (HL), derived from the condensation reaction of 2-amino-1-butanol and 
salicyldehyde. Complex 1 has been characterized by X-ray crystal structure, FT-IR, electronic 
absorption and fluorescence spectroscopic methods. The structural determination reveals that 
complex 1 crystallizes in the monoclinic system with space group P21/n and form 1D polymeric 
chain, built by bridging fum. Weak π…π and C–H…π interactions in 1, lead to a 3D 
supramolecular architecture. Complex 1 exhibits fluorescence at room temperature with a quantum 
yield (Φs) of 0.257. The interactions of complex 1 with bovine serum albumin (BSA) and human 
serum albumin (HSA) were studied using electronic absorption and fluorescence spectroscopic 
techniques and the analysis shows that complex 1 interaction with BSA / HSA occurs mainly with 
ground state association process. Calculated values of apparent association constants are 1.34 × 
104 M-1 and 1.81 × 104 M-1 for BSA and HAS, respectively,  at 300 K.  The number of binding 
sites and binding constants were calculated using double logarithm regression equation. The 
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interaction of complex 1 with the calf thymus DNA (CT-DNA) was also investigated using 
electronic absorption and fluorescence spectroscopic methods. The results show that complex 1 
has binding affinity to CT-DNA in the order of 2.96×105 M-1. Low temperature magnetic 
measurements reveal existence of antiferromagnetic interaction in complex 1. The magnetic data 
have been fitted considering complex 1 as a pseudo-dinuclear system, with the two copper(II) 
atoms bridged by two carboxylate oxygen atoms, since the coupling through long fum bridge is 
almost nil. The best-fit parameters obtained with this model are J = – 60 cm-1, gCu = 2.20. 
 
Introduction  
The design and synthesis of polynuclear metal complexes have become and active area of research 
for the last few decades due to their interesting molecular structure, crystal packing motifs and 
potential application in the field of magnetism,1 fluorescence,2 catalysis3  and bio-inorganic 
chemistry.4 The choice of ligands is one of the important factors for designing such polynuclear 
metal complexes. Chelating organic ligands block some coordination sites of the metals ions, 
whereas the organic spacers serve to link the metal ions and form polynuclear metal complexes.5 
Multidentate flexible Schiff bases are often used to build polynuclear complexes, since they can 
efficiently block some coordination sites of metal ions.6 The use of Schiff base in combination 
with the linear dicarboxylate is an important strategy for synthesis of polynuclear complexes and 
in this combination the Schiff bases function as chelating ligand and linear dicarboxylate behaves 
as spacer.7 Among the 3d metal ions the polynuclear chemistry of Cu(II) is very important since it 
exhibits a rich variety of coordination geometries e.g., tetragonal, tetrahedral, square planar, 
trigonal bipyramidal etc. and hence the prediction of final structure and molecular topology of 
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polynuclear copper (II) compounds is difficult.8 On the other hand  copper compounds show 
interesting magnetic properties,9 anticancer activity10 and bio-inorganic modeling.11  
Fumaric acid (H2fum), as a member of multidentate aliphatic dicarboxylic acids, possesses 
versatile coordination mode and have special conformation with a 180° angle between the 
carboxylic acid groups. It can function as mediator for transmitting the exchange interaction 
between the paramagnetic metal centers.12 It has been scarcely used to construct the Cu(II) 
polynuclear complexes and to our knowledge only a few compounds of Cu(II) with fum2- have 
been reported in the literature.13 Since the metal-metal distance through the  fum2- ligand is above 
9.2 Å, the bridging spacer does not effectively transmit magnetic exchange, however fum2- 
sometimes function as monoatomic bridging mode and exhibit ferromagnetic exchange 
interaction.13a 
Literature survey reveals that many copper(II) based coordination compounds  are used as metallo-
pharmaceuticals14 and these compounds  play an important role in biology due to their 
antimicrobial,15 antifungal,16 antibacterial,17 antitumoral,18 antiviral,19 antipyretic16a and 
antidiabetic activities.20 The study of the interaction of copper(II) compounds with DNA under 
physiological conditions is important for the design of copper(II) based new pharmaceuticals. On 
the other hand, serum albumin is the most abundant soluble protein in the circulatory system and 
function as transporter and disposer of pharmaceuticals.21 For this reason the analysis of kinetics 
of the interaction of DNA / serum albumins and copper complex is important to determine the 
affinity of copper complex to DNA / protein, and this information will promote the development 
of copper metal based efficient metallopharmceuticals. In the present contribution we report 
synthesis, crystal structure and magnetic properties of a 1D polynuclear copper(II) compound, 
{[Cu2(L)2(fum)]∙H2O}n (1) (fum = fumarate ; HL = (E)-2-((1-hydroxybutan-2-
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ylimino)methyl)phenol). Kinetics of interactions of complex 1 with calf thymus DNA (CT-DNA) 
and bovine / human serum albumins have been studied. 
 
Experimental   
Materials. High purity 2-amino-1-butanol was purchased from the Aldrich Chemical Co. Inc. and 
used as received. All other chemicals used were of analytical grade. Solvents used for 
spectroscopic studies were purifies and dried by standard procedures before use.22 
Physical measurements. Elemental analyses (carbon, hydrogen and nitrogen) were performed 
using a Perkin-Elmer 240C elemental analyzer. IR spectra were recorded as KBr pellets on a 
Bruker Vector 22FT IR spectrophotometer operating from 400 to 4000 cm–1. Electronic absorption 
spectra were obtained with Shimadzu UV-1601 UV-vis spectrophotometer at room temperature. 
Quartz cuvettes with a 1 cm path length and a 3 cm3 volume were used for all measurements. 
Emission spectra were recorded on a Hitachi F-7000 spectrofluorimeter. Room temperature (300 
K) spectra were obtained in methanolic solution using a quartz cell of 1 cm path length. The slit 
width was 2.5 nm for both excitation and emission.  
The fluorescence quantum yield was determined using phenol as a reference and methanol 
medium for both complexes and reference. Emission spectra were recorded by exciting the 
complex and the reference phenol at the same wavelength, maintaining nearly equal absorbance 
(~ 0.1). The area of the emission spectrum was integrated using the software available in the 



















where Φs and Φr are the fluorescence quantum yield of the sample and reference, respectively. As 
and Ar are the respective optical densities at the wavelength of excitation, Is and Ir correspond to 
the areas under the fluorescence curve; and ηs and ηr are the refractive index values for the sample 
and reference, respectively.  
Temperature-dependent molar susceptibility measurements of polycrystalline sample was carried 
out at the Servei de Magnetoquímica of the Centres Científics i Tecnològics at the Universitat de 
Barcelona in a Quantum Design SQUID MPMSXL susceptometer with an applied field of 3000 
and 198 G in the temperature ranges 2–300 and 2–30 K, respectively. 
Synthesis of the ligands : 
A methanolic solution (20 mL) of mixture of 2-amino-1-butanol (1 mmol, 0.089 g) and 
salicyldehyde (1 mmol, 0.122 g) was refluxed for 3h. The resulting yellow colour solution cooled 
to room temperature and solid yellow compound was obtained after evaporation of solvent under 
reduced pressure. The compound obtained was redissolved in MeOH and filtered. The solution 
was left for slow evaporation at room temperature. After one week, yellow crystals of HL were 
obtained. Yield: 85%. Anal.Calc. for C11H15NO2 (193.24): C, 68.36; H, 7.82; N, 7.24 %. Found: 
C, 68.34; H, 7.79; N, 7.26 %. HR-MS: [M + H]+, m/z, 194.25 (100%) calcd: m/z, 193.24. 1H NMR 
(400 MHz, CDCl3, δ ppm): 0.709-0.886 (3H, m), 1.474-1.655 (2H, m), 2.576 (1H, s), 3.466-3.690 
(1H, m; 2H, m), 4.957 (1H, s), 6.823-6.921 (1H, d; 2H, m), 7.226-7.298 (1H, d; 2H, m), 8.306 
(1H, s). 13C NMR (CDCl3, 400 MHz, δ ppm): 165.41 (Ar−C−OH), 161.71 (−CH=N−), 132.45-
113.71 (Ar−C), 73.03 (-CH2-OH), 66.23 (=N-CH-), 25.05 (-CH2-), 10.51 (-CH3).  
 
 
Synthesis of complexes 
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Caution! Metal perchlorates in the presence of organic ligands are potentially explosive. Only a 
small amount of the material should be prepared and handled with care. 
The complex has been synthesized by adopting the procedure schematically given in 
Scheme 1. 
Scheme 1. Synthesis of complex 1 
 
Synthesis of {[Cu2(L)2(fum)]∙H2O}n (1). A methanolic solution (10 mL) of mixture of HL (1 
mmol, 0.193 g) and triethylamine (TEA) (1 mmol) was added to a methanolic solution (10 mL) of 
Cu(ClO4)2∙6H2O (1.0 mmol, 0.371 g), and  stirred for 2h. To the resulting green mixture an aqueous 
solution (1 mL) of disodium fumarate (1mmol, 0.16 g) was added dropwise and resulting deep 
green reaction mixture was stirred for an additional 1 h at 27 °C and filtered. The filtrate was kept 
in air for slow evaporation at room temperature. Deep green needle shaped single crystals suitable 
for X-ray diffraction were obtained by slow evaporation of methanolic solution after a few days. 
Yield 78 %.  Anal. Calc. for C26H32Cu2N2O9 (643.62): C, 48.47; H, 4.97; N, 4.35 %. Found: C, 
48.50; H, 4.99; N, 4.37 %. IR (cm-1): 3200-3600 (br, vs), 2982 (w), 1642 (s), 1552 (vs), 1468 (s), 
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1416 (vs), 1374 (s), 1302 (vs), 1244 (vw), 1196 (vw), 1082 (vw), 1021 (vw), 888 (vw), 691 (br, 
vw). 
Crystallographic data collection and refinement. 
The crystal data of complex 1 was collected at room temperature using a Nonius Kappa CCD 
diffractometer with graphite monochromated Mo-K radiation. The data set was integrated with 
the Denzo-SMN package24 and corrected for Lorentz, polarization and absorption effects 
(SORTAV).25 The structure was solved by direct methods using SIR9726 system of programs. The 
structure of 1 was refined using full-matrix least-squares with all non-hydrogen atoms 
anisotropically and hydrogens included on calculated positions, riding on their carrier atoms, 
except the hydrogen atoms forming H-bonds which were refined isotropically. The methyl group 
C26-H3 was found disordered and refined isotropically over two positions with occupancies of 0.6 
and 0.4, respectively. The structure displays large voids occupied by disordered solvent molecules 
which cannot be localized. These solvent molecules have been treated as a diffuse contribution to 
the overall scattering without specific atom positions using the routine SQUEEZE included in the 
PLATON systems of programs.27 All calculations were performed using SHELXL-9728 and 
PARST29 implemented in WINGX30 system of programs. Crystallographic data has been deposited 
at the Cambridge Crystallographic Data Centre and allocated the deposition numbers CCDC 
1476311. The crystal data are given in Table 1 and a selection of bond distance and angles are 
given in Table 2. 
Albumin Binding studies       
Stock solutions of human serum albumin (HAS, 3.109 µM) and bovine serum albumin (BSA, 
8.214 µM) were prepared in HEPES buffer (pH 7.2) solution. Aqueous solution of the copper(II) 
compound was prepared by dissolving the compound  in water : HEPES buffer (1:99). The 
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interactions of compound with serum albumins were studied by recording room temperature 
tryptophan fluorescence of HSA / BSA at 340 nm. Fluorescence spectra were recorded in the range 
290-450 nm at an excitation wavelength of 280 nm.  To the solutions of serum albumins, copper(II) 
compound was added and the quenching of emission intensities at 340 nm (λex, 280 nm) were 
recorded after gradual addition (20 µL, 0.199 µM) aqueous solution compound. The Stern-Volmer 
constant (Ksv) and quenching rate constant (kq) were calculated using the equations F0/F = 1 + 
Ksv[complex] and Ksv =  kqτ0, where F0 and F are the fluorescence intensity in the absence and in 
the presence of the complex, and τ0 is the lifetime of serum albumin (~ 5 × 10
-9 s).31  To calculate 
the binding constant of the compound with SA, the following Scatchard equation have been used  
            log[(Fo–F)/F] = log Kb + n log[complex], where Kb is the binding constant of the compound with 
serum albumin and n is the number of binding sites per albumin. 
DNA binding studies 
Absorbance spectral studies 
UV spectroscopic technique has been used to investigate the possible binding mode and to 
calculate the intrinsic binding constant (Kib) for the interaction of the complex with CT-DNA. 
Electronic absorption spectral titration was carried out at a fixed concentration of copper(II) 
compound (11.26 µM) in water and varying the concentration of CT-DNA from 0 to 23.21 µM. 











where, [DNA] is the concentration of  CT-DNA, εa is the extinction co-efficient of the complex at 
a given CT-DNA concentration, εf  and εb are the extinction co-efficient of the complex, in free 
solution and when fully bound to CT-DNA, respectively. The plot of [DNA]/(εa-εf) vs [DNA] give 
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a straight line with 1/(εb-εf) and 1/[Kib(εb-εf)] as slope and intercept, respectively. From the ratio 
of the slope to the intercept the value of Kib was calculated. 
Competitive binding fluorescence measurement 
The competitive binding nature of ethidium bromide (EB) and copper(II) compound with CT-
DNA was investigated adopting fluorometric method using aqueous solution of EB bound CT-
DNA in HEPES buffer (pH 7.2) at room temperature. In presence of DNA, ethidium bromide (EB) 
exhibits fluorescence enhancement due to its intercalative binding to DNA. Competitive binding 
of copper(II) compound with CT-DNA results fluorescence quenching due to displacement of EB 
from CT-DNA. The fluorescence intensities at 612 nm (λex, 500 nm) of EB bounded CT-DNA 
with increasing concentration of copper(II) compound was recorded. The Stern-Volmer constant 
(Ksv) was calculated using Stern-Volmer equation
33 F0/F = 1 + Ksv[complex] ,where F0 and F are 
the emission intensity in absence and in presence of copper(II) compound, Ksv is the Stern-Volmer 
constant, and [complex] is the concentration of copper (II) compound. 
Results and discussion   
Crystal structure description 
Complex 1 crystallizes in the monoclinic system with space group P21/n. Crystallographic data 
and selected bend lengths and bond angles are depicted in Table 1 and Table 2. The ORTEP34 view 
of the asymmetric unit is shown in Fig.2 and the polymeric structure is shown in Fig.3. The crystal 
structure analysis complex 1 shows that the Cu2(L
1)2 units are connected by fumarate spacer, 
beside the presence of lattice water molecules. The crystallographic independent unit contains two 
copper(II) cation, two deprotonated Schiff base (L1)− , one fumarate and one lattice water molecule. 
Copper atoms of asymmetric unit are again connected with fumarate and form ID coordination 
polymeric structure (Fig.3). The coordination polyhedron for each metal is best described as 
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slightly distorted square pyramidal geometry [trigonality τ5 parameters
35 are 0.128 and 0.013 for 
Cu(1) and Cu(2), respectively]. The basal plane is occupied by the chelating tridentate Schiff base 
donors [O(1), N(1), O(2) for Cu(1) and O(7), O(8), N(2), for Cu(2)] and by the fumarate oxygen 
donors [O(3) and O(5) for Cu(1) and Cu(2), respectively]. The apex of the square pyramid 
occupied by another fumarate oxygen at relatively longer distance [Cu(1)-O(5)' 2.384(5) Å; Cu(2)-
O(3)'' 2.476(4) Å (Table 2)]. The copper atoms are displaced by 0.0363 and 0.013 Å for Cu(1) and 
Cu(2), respectively, from the respective basal planes. The coordination Cu-O bond distances are 
varying in the range 1.908 - 2.384 Å and 1.909 - 2.476 Å for Cu(1) and Cu(2), respectively.  The 
cisoid bond angle ranges are 78.46 - 94.95° for Cu(1) and 76.25 - 94.48° Cu(2) center. On the 
other hand the transoid bond angles are 166.88°,  174.56° (for Cu(1)), and 175.30°, 176.13 ° (for 
Cu(2)). The packing diagram of complex 1 indicates that it exists as 1D polymeric chain through 
fumarate linkage where Cu…Cu separation is 8.99Å. A weak coordinative interaction between 
Cu(1) and O(4) atoms [Cu(1)-O(4) 2.768 Å] also exists in the 1D chain. The 1D polymeric chains 
are involve in strong π…π interactions (Fig.1S) (centroid to centroid distance 3.66 Å, Table 1S) 
and results 2D supramolecular sheets. Two such different 2D sheets   are further connected with 
C–H…π interactions36 (C–H…π (ring), 3.004 Å) and form a 3D supramolecular network (Fig.4).  
IR, electronic absorption and fluorescence spectra of 1 
IR spectrum of complex 1 is shown in Fig. 2S, and the most important absorption bands are 
summarized in the experimental section. The spectrum of complex 1 shows broad band in the 
region 3100 - 3600 cm-1 corresponding to the ν(O-H) stretching vibrations37. The band at 2982 cm-
1 is due to the ν(C-H) stretching vibration. The asymmetric and symmetric stretching vibrations of 
carboxylate group appear at 1642 and 1416 cm-1, respectively. The strong and sharp band at 1552 
cm-1 is due to the aliphatic C=N) stretching vibration.  
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The electronic spectrum of complex 1 shows (Fig. 5) significant transitions at 222 (ε ~ 4.98 × 104 
M-1 cm-1), 238 (ε ~ 4.40 × 104 M-1 cm-1), 268 (ε ~ 2.72 × 104 M-1 cm-1) and 366 (ε ~ 1.03 × 104 M-1 cm-
1) nm. Study of the luminescence property (Fig.5) of complex 1 shows red shifted emission (Table 
3) with large Stokes shifts (44 - 96 nm). On excitation at 366 nm complex 1 exhibits emission at 
410, 433 and 462 nm in methanol with a fluorescence quantum yield φ = 0.257, at room 
temperature. This band positions remain unchanged when λex varied between 356 and 376 nm.  
Protein binding studies  
Serum albumin binding study using absorption spectroscopy  
The change of electronic absorption spectra of bovine serum albumin (BSA) (3 ml, 8.214 µM 
aqueous solution) and human serum albumin (HSA) (3 ml, 3.109 µM aqueous solution) in presence 
of different concentration (0 - 14.748 µM)  of complex 1 (using HEPES buffer, pH 7.2) at 300 K 
temperature is shown in Fig. 6. Spectral band at 280 nm of both serum albumins blue shifted in 
presence of complex 1 (6 nm for BSA, 7 nm for HAS at 27 °C; 7 nm for BSA, 8 nm for HAS at 
37 °C). Bathochromic shift at 280 nm confirms the ground state association of complex 1 with 











           where Aobs is the observed absorbance at 280 nm of the solution containing different concentrations 
of the complex, A0 is the absorbance of serum albumin only and Ac is the absorbance of serum 
albumin with complex 1. From the plot (Fig.7) of 1/(Aobs-A0) vs 1/[complex] the  values of 
apparent association constants were calculated and the calculated values are 1.34 × 104 L mol-1 
and 1.81 × 104 L mol-1 for BSA and HAS, respectively,  at 300 K (Table 4). 
12 
 
Fluorescence quenching of serum albumins by complex 1 
The binding interactions of serum albumins with the complex were studied by fluorescence 
spectroscopy. On excitation at 280 nm, aqueous solution (pH 7.2, HEPES buffer) of serum 
albumins (BSA/HAS) exhibit luminescence at 340 nm.  The change of fluorescence spectra of 
BSA and HAS upon addition of increasing concentration (0 - 11.269 µM) of complex 1 are shown 
in Fig.8. Significant decrease in fluorescence intensity (up to 68.67 % with 3 nm blue shift  for 
BSA and  up to 63.19 % with 2 nm blue shift for HAS) observed at 340 nm upon gradual addition 
of 20 µL, 0.199 µM aqueous solution of complex 1 to the solution of serum albumins. This 
hypochromicity in the spectra reveals that complex binds with serum albumins. From the Stern-
Volmer equation33 a linear relationship were obtained (R = 0.988 for BSA curve; R = 0.994 for 
HSA curve) for the titration of serum albumins using complex 1 as quencher (Fig. 8, inset). The 
calculated values of Stern-Volmer quenching constants (Ksv) are 2.09 × 10
5 L mol-1 (for BSA) and 
1.39 × 105 L mol-1 (for HSA). Calculated values of the quenching constants (kq) are 4.18 × 10
13 L 
mol-1 s-1 and 2.79 × 1013 L mol-1 s-1for BSA and HAS, respectively (Table 4). The values of Ksv 
and kq indicate that complex 1 has good fluorescence quenching ability.  The UV-vis absorption 
spectra of BSA/HAS show significant change on addition of complex 1, this phenomenon indicate 
the existence of static interaction between BSA/HSA and complex 1. The presence of static 
interaction is again supported by the very high values of kq  ( ~ 10
13 L mol-1 s-1),  these are much 
greater than the maximum values (2×1010  L mol-1 s-1) of diffusion collision  quenching rate 
constant  of various kind of fluorescence quenchers for biopolymer.38 The binding constants (Kb) 
for the interaction of serum albumins with complex 1 and the number of binding sites (n) per 
albumin were also calculated using Scatchard equation. The plot of  log
(Fo−F)
F
 vs log[complex] 
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gives a straight line (Fig.9) with n and logKb as slope and the intercept, respectively. Calculated 
values of kb and n are given in Table 4. 
DNA binding studies of complex 
Electronic absorption spectral titration 
           The intercalation between a compound and DNA39 is evident by the hypochromism in the electronic 
spectra of compound with or without red / blue shift upon gradual increasing concentration of 
DNA. On the contrary non-intercalative interaction between the compound and DNA supported 
by the hyperchromism in the absorption spectra of a compound with increasing concentration of 
DNA.40  Fig.10 displays the change in the electronic absorption spectra of complex 1 (0.199 µM 
aqueous solution) with increasing concentration of  CT-DNA (0 - 20.94 µM). The hypochromism 
of about 48.14, 25.14, and 25.18 % were observed for the spectral bands at 238, 268, and 366 nm, 
respectively. The bands at 238 and 268 nm showed  hypochromism with 2 nm red shift and 1 nm 
blue shift, respectively, where no shifting observed for  366 nm  band. These spectral changes 
indicate that complex 1 bind to the CT-DNA helix via intercalation. [DNA]/(𝜀𝑎 − 𝜀𝑓) vs [DNA] 






 as slope and intercept, respectively. The 
values of intrinsic binding constant (Kib) was calculated from the ratio of slope to the intercept and 
calculated value of Kib is 2.96×10
5 L mol-1. 
Ethidium Bromide (EtBr) displacement studies 
Ethidium bromide (EtBr = 3,8-diamino-5-ethyl-6-phenyl phenanthridinium bromide) shows 
fluorescence with an orange colour, when it exposed to ultra violet radiation. The intensity of EtBr 
fluorescence increases around 20 fold in presence of CT-DNA due to strong intercalation of the 
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planar ethidium bromide phenanthridium ring between adjacent base pair of the double helix.41 
CT-DNA bounded EtBr shows emission at 612 nm on excitation at 500 nm. Addition of a 
compound, which is capable to interact with CT-DNA, to the solution of a mixture of EtBr-CT-
DNA results in the quenching of EtBr-CT-DNA fluorescence intensity. The quenching of 
fluorescence occurs due to decrease in the number of binding sites on the CT-DNA available for 
EtBr. The fluorescence quenching observed in presence of compound may be used to study 
intercalation between CT-DNA and this compound. Fig.11 shows the change of fluorescence 
spectra of CT-DNA bounded EtBr upon gradual addition of 20 µL 0.199 µM solution of complex 
1.  Hypochromism (up to 65.58 % of the initial fluorescence intensity of 612 nm band) in presence 
of complex 1 suggests that it displaced EtBr molecule from the DNA binding sites.[41, 42] From the 
Stern-Volmer plot33  (insets of Fig. 11) the binding constant (Ksv) was calculated and it  is 1.701 × 
105 L mol-1. 
Magnetic properties of complex 1 
Temperature-dependent magnetic susceptibility measurements on a polycrystalline sample of 
complex 1 were carried out in the temperature range 1.9-300 K. The plot of χMT versus T is shown 
in Fig. 12, where χM is the molar magnetic susceptibility and T is the absolute temperature. The 
χMT value measured at room temperature of 0.84 cm
3 K mol-1 is slightly higher than the expected 
value for two uncoupled S = ½  spins assuming g = 2 (0.75 cm3 K mol-1). Upon cooling, χMT varies 
smoothly and finally drops to zero, reaching a plateau at temperatures below 10 K. The behavior 
displayed by complex 1 confirms the presence of an overall antiferromagnetic interaction in the 
complex. The experimental magnetic data were simulated with the MAGPACK program.43 The 
model assumed the crystallographic equivalence of the two Cu(II) ions within the dinuclear unit 
by assigning one single g value for both ions. Additionally, the interaction between Cu2 units 
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through the fumarate bridge was considered negligible, since it is expected to be between one and 
two orders of magnitude weaker than the interaction with in the Cu2 dinuclear unit.
44 For the spin 
Hamiltonian H = –JS1S2, S1 = S2 = SCu, a good agreement between the experimental and simulated 
curves for 1 was found by using the following parameters: gCu = 2.20 and JCu-Cu= –60 cm
-1. 
Temperature-independent paramagnetism (TIP) was considered equal to 150 × 10-6 cm3mol-1. The 
simulated curve is represented together with the experimental values in Fig.12. 
The antiferromagnetic coupling in complex 1 can be understood in the light of orbital symmetry 
considerations. The two copper(II) ions in the asymmetric unit are penta-coordinated and the two 
square pyramids formed are sharing one base-to-apex edge with parallel basal planes.45 The 
unpaired electron in each Cu(II) ion  resides mainly in the basal dx2-y2 orbital. Thus, the two parallel 
magnetic orbitals are orthogonally connected through an axial position occupied by the 
monodentate fumarate bridge. If a perfect square-pyramid environment ( = 0) is assumed for both 
Cu(II) ions, there would be no overlap between their magnetic orbitals, and consequently the 
magnetic interaction would be negligible or weakly ferromagnetic. However, in complex 1 only 
Cu2 shows a local geometry close to that of a perfect square-pyramid ( = 0.013), while Cu1 
exhibits a larger distortion ( = 0.128). Such distortion is responsible for an increase of the overlap 
between dx2-y2 magnetic orbitals in the asymmetric unit, and as a result a moderate 
antiferromagnetic exchange operates between the two Cu(II) ions.46  
 
Conclusion   
In summary, we have presented here the synthesis, crystal structure, low-temperature magnetic 
behavior and study of the interactions with BSA/HAS and CT-DNA of a novel fumerate (fum) 
bridged complex of copper(II) using O,N,O donor chelating ligand. Copper(II)-Schiff base  in 
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combination with  linear rigid carboxylate fum generates a 1D polymeric chain. 3D supramolecular 
architecture of compound realized through π…π and C–H…π interactions. The CT-DNA and 
protein binding of the copper(II) complex was investigated using electronic absorption and 
fluorescence spectroscopic techniques. The compound binds effectively to CT-DNA through 
intercalation and the calculated value of intrinsic binding constant was 2.96×105 L mol-1. 
Fluorescence spectroscopic study shows that interaction of complex with serum albumins occurs 
through ground state association process and the calculated value of the quenching constants are 
in the order of 1013 L mol-1 s-1.  Low temperature magnetic measurement reveals existence of 
antiferromagnetic interaction in this compound. Experimental magnetic data of the compound 
were fitted with a pseudo-dinuclear copper (II) model where the two paramagnetic ions are bridged 
by two carboxylate groups and assuming that the coupling through long bridging fum is almost 
nil. 
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Table 1 Crystal Data and Structure Refinement for complex 1 
Empirical formula C26H32Cu2N2O9 
Formula mass, g mol–1 643.62 
Crystal system Monoclinic 











T/K  295 
Dc/g cm
-3 1.445 
(Mo-Kα)/ cm–1 14.89 
F(000) 1328.0 
θmin- θmax/° 3.07-25.50 
Measured Reflections 15779 
Unique Reflections 5472 
Rint 0.0733 
Obs. Refl.ns [I2σ(I)] 3525   
hkl ranges -10,10;-16,16;-25,31 
Goodness of fit (F2) 1.041 
No. Variables/Restraints 379/5 
R(F2) (Obs.Refl.ns) 0.0709 
wR(F2) (All Refl.ns) 0.1754 
Δρmax; Δρmin /e Å
-3 0.615; -0.557 
 
Table 2 Selected bond distances (Å) and angles (°) of complex 1 
Bond distances 
Cu(1)-O(1)        1.908(4) Cu(2)-O(5) 1.944(4) 
Cu(1)-O(2) 2.050(5) Cu(2)-O(7) 1.909(4) 
Cu(1)-O(3) 1.947(4) Cu(2)-O(8) 1.995(4) 
Cu(1)-N(1) 1.930(5) Cu(2)-N(2) 1.938(5) 
Cu(1)-O(5)' 2.384(5)  Cu(2)-O(3)'' 2.476(4) 
Bond angles 
O(1)-Cu(1)-O(2) 174.6(2) O(7)-Cu(2)-O(8) 176.1(2) 
O(1)-Cu(1)-O(3) 94.2(2) O(7)-Cu(2)-O(5) 90.2(2) 
O(1)-Cu(1)-N(1) 95.0(2) O(7)-Cu(2)-N(2) 94.5(2) 
O(1)-Cu(1)-O(5)' 94.5(2) O(7)-Cu(2)-O(3)'' 92.5(2) 
O(2)-Cu(1)-O(3) 89.4(2) O(8)-Cu(2)-O(5) 93.1(2) 
O(2)-Cu(1)-N(1) 82.2(2) O(8)-Cu(2)-N(2) 82.3(2) 
O(2)-Cu(1)-O(5)' 82.1(2) O(8)-Cu(2)-O(3)'' 90.3(2) 
O(3)-Cu(1)-N(1) 166.9(2) O(5)-Cu(2)-N(2) 175.3(2) 
O(3)-Cu(1)-O(5)' 78.5(2) O(5)-Cu(1)-O(3)'' 76.2(2) 
N(1)-Cu(1)-O(5)' 110.1(2) N(2)-Cu(1)-O(3)'' 102.9(2) 
25 
 
Symmetry operations: (') at x+1,y,z and ('') atx-1,y,z 
 
 
Table 3 Photophysical parameters of complex 1. 




Complex 1 222 (0.498 × 105), 238 (0.440 × 105), 
268 (0.272 × 105), 366 (0.103 × 105) 
410, 433, 
462 
44, 67, 96 0.257 




Table 4 Apparent binding constant (Ka), Stern-Volmer constant (Ksv), quenching constant (Kq), 
binding constant (Kb) and number of binding site (n) of BSA and HSA. 
 Ka (L mol
-1) Ksv (L mol
-1) Kq (L mol
-1s-1) Kb (L mol
-1) n 
BSA 1.3468 × 104 2.0933 × 105 4.1866 × 1013 7.8324 × 105 1.34 
HSA 1.8153 × 104 1.397 × 105 2.794 × 1013 7.5557 × 105 1.14 
 
 
Table 5 DNA binding constant (Kb), quenching constant (Kq) and apparent binding constant (Kapp) 












Fig. 1. 1H (a) and 13C NMR (b) spectra of HL. 
 
 





Fig.3. The polymeric structure of complex 1 determined by the Cu1…O5 and Cu2…O3 
interactions.  
 
















Fig.6. Change of electronic absorption spectra of BSA (a) and HAS (b) upon gradual addition of 








Fig.7. Plot of 1/(Aobs - A0) vs reciprocal of complex 1 concentration for titration with BSA (a) 









Fig.9. Double-logarithm curves of BSA and HSA fluorescence quenching by complex 1 
 
 
Fig.10. Electronic absorption spectra of complex 1 in the absence and presence of increasing 
amount of CT-DNA. Arrows show the changes in absorbance with respect to an increase in the 




Fig.11. Emission spectra of EB-DNA in the presence of complex 1.  Arrow indicates the change 
in the emission intensity as a function of complex concentration. Inset: Stern-Volmer plot of the 
fluorescence titration data corresponding to the complex 1. 
 
 
Fig.12.  χMT vs. T plot for complex 1 (solid line represents the best fit). 
 
 
